This is a multi-centre randomised trial of chemotherapy with chemotherapy plus radioembolisation for colorectal cancer that has spread to the liver
SUMMARY
An open-label randomised phase III trial of 5-Fluorouracil, OXaliplatin and Folinic acid +/- Interventional Radio-Embolisation as first line treatment for patients with unresectable liver-only or liver-predominant metastatic colorectal cancer.
The aim of the trial is to compare chemotherapy alone (5-FU, oxaliplatin & folinic acid) with chemotherapy plus radioembolisation for colorectal cancer that has spread to the liver.
Primary Objectives
- Overall survival
Trial Publications
The study protocol publication can be found here.
The primary results publication can be found here.
Secondary publications can be found as follows:-